Pliant Therapeutics (PLRX) Shareholder's Equity (2019 - 2026)
Pliant Therapeutics (PLRX) Shareholder's Equity (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Shareholder's Equity (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
7.14 Bn |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
795.79 Mn |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
595,226.00 |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
1.00 Bn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
14.38 Mn |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
19.36 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
502.95 Mn |
| 10 |
Pliant Therapeutics |
71.07 Mn |
71.07 Mn |
- |
165.17 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
165.17 Mn |
| Dec 31, 2025 |
181.21 Mn |
| Sep 30, 2025 |
200.31 Mn |
| Jun 30, 2025 |
220.08 Mn |
| Mar 31, 2025 |
257.16 Mn |
| Dec 31, 2024 |
304.08 Mn |
| Sep 30, 2024 |
345.82 Mn |
| Jun 30, 2024 |
392.68 Mn |
| Mar 31, 2024 |
437.33 Mn |
| Dec 31, 2023 |
473.58 Mn |
| Sep 30, 2023 |
503.05 Mn |
| Jun 30, 2023 |
533.07 Mn |
| Mar 31, 2023 |
561.92 Mn |
| Dec 31, 2022 |
313.34 Mn |
| Sep 30, 2022 |
336.99 Mn |
| Jun 30, 2022 |
147.79 Mn |
| Mar 31, 2022 |
173.79 Mn |
| Dec 31, 2021 |
199.06 Mn |
| Sep 30, 2021 |
220.44 Mn |
| Jun 30, 2021 |
243.98 Mn |
